LSTA1-GBM-2A: study protocol for an exploratory phase 2a randomised controlled trial evaluating tumour-homing peptide certepetide with temozolomide in glioblastoma multiforme Johannes Pärtel Truusalu 2025-11-17
LinTT1-Functionalized Hybrid Lipid-Polymer Nanoparticles for Glioblastoma Targeting Antonella Rocchi 2025-10-16
Targeting oncofetal fibronectin and neuropilin-1 in solid tumors with PL2 peptide Prakash Lingasamy 2025-08-11
Identification of splenic IRF7 as a nanotherapy target for tele-conditioning myocardial reperfusion injury Qiang Long 2025-02-24
Screening of homing and tissue-penetrating peptides by microdialysis and in vivo phage display Toini Pemmari 2025-02-11
Peptide-Drug Conjugate for Therapeutic Reprogramming of Tumor-Associated Macrophages in Breast Cancer Anni Lepland 2025-01-22
Effects of LinTT1-peptide conjugation on the properties of poly(ethylene glycol)-block-(ε-caprolactone) nanoparticles prepared by the nanoprecipitation method Voitto Känkänen 2025-01-03
A Cyclic Peptide Targets Glioblastoma by Binding to Aberrantly Exposed SNAP25 Alberto G Arias 2024-11-22
A CYCLIC PEPTIDE TARGETS GLIOBLASTOMA BY BINDING TO ABERRANTLY EXPOSED SNAP25 Alberto G Arias 2024-09-30
Unlocking the potential of nanomedicine: advances in precision targeting strategies Christian Celia 2024-08-02
Targeting vascular disrupting agent-treated tumor microenvironment with tissue-penetrating nanotherapy Valeria Sidorenko 2024-07-30
PL3 CendR peptide shows specific uptake in cultured Y79 retinoblastoma cells with nucleolar accumulation Sonja Korhonen 2024-07-27
Protease-activated CendR peptides targeting tenascin-C: mitigating off-target tissue accumulation Allan Tobi 2024-07-16
Mechanisms and Barriers in Nanomedicine: Progress in the Field and Future Directions Thomas Anchordoquy 2024-05-20
Targeting triple-negative breast cancer cells with a β1-integrin binding aptamer Karlis Pleiko 2023-09-08
Intravitreal CendR peptides target laser-induced choroidal neovascularization sites in mice Jooseppi Puranen 2023-07-20